Bayer AG. (8/30/18). "Press Release: Bayer Receives US Approval for Modern Hemophilia A Treatment Jivi with a Step-wise Prophylaxis Dosing Regimen [Not intended for U.S. and UK Media]". Berlin.

	Region	United States (USA)
	Organisation	Bayer AG
	Group	Bayer (Group)
	Organisation 2	FDA (US Food and Drug Administration)
	Group	United States (govt)
	Product	Jivi®
	Product 2	clinical research
	Person	Möller, Jörg (Bayer 201403 Bayer HealthCare Head of Global Development)

Original document
accessed by [iito] on 2018-09-04

Record changed: 2018-09-05

More documents for Bayer (Group)

[1] Bayer Corporation. (11/26/18). "Press Release: FDA Approves Vitrakvi (larotrectinib), the First Ever TRK Inhibitor, for Patients with Advanced Solid Tumors Harboring an NTRK Gene Fusion". Whippany, NJ & Stamford, CT....
[2] Compugen Ltd.. (11/7/18). "Press Release: Compugen Reports Third Quarter 2018 Results". Holon....
[3] Genedata AG. (9/27/18). "Press Release: Bayer Partners with Genedata to Digitalize Crop Science Research and Development". Basel....
[4] Celyad S.A.. (9/26/18). "Press Release: Celyad Appoints Carri Duncan as Vice-President Corporate Development and Communications". Mont-Saint-Guibert....
[5] Cellectis S.A.. (9/18/18). "Press Release: Calyxt Appoints CEO, Jim Blome, Former President & CEO of Bayer CropScience LP". Minneapolis, MN & New York, NY....
[6] Sanofi S.A.. (9/13/18). "Press Release: Sanofi to Refocus Two Global Business Units". Paris....
[7] Bayer AG. (8/24/18). "Press Release: Bayer Secures Approval in the EU for Xarelto (rivaroxaban) for Patients with Coronary or Peripheral Artery Disease [Not intended for U.S. and UK Media]". Berlin....
[8] Evotec AG. (7/19/18). "Press Release: Evotec Receives Milestone Payment for Start of Phase II Trial in Its Multi-target Alliance with Bayer". Hamburg....
[9] High-Tech Gründerfonds Management GmbH. (5/29/18). "Press Release: Bayer and Boehringer Ingelheim Invest in HTGF III"....
[10] Calyxt, Inc.. (5/15/18). "Press Release: Bayer CropScience, LP Agrees to Settle Lawsuit Filed by Calyxt in Delaware Chancery Court". Minneapolis, MN....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

» top

Top News

Upcoming Events

Bio Regions & Life Sciences Clusters

Business Parks & Science Centres

Associations

Partners

Bayer AG. (8/30/18). "Press Release: Bayer Receives US Approval for Modern Hemophilia A Treatment Jivi with a Step-wise Prophylaxis Dosing Regimen [Not intended for U.S. and UK Media]". Berlin.

More documents for Bayer (Group)